Michael Cherny
Stock Analyst at Leerink Partners
(2.15)
# 1,364
Out of 4,479 analysts
71
Total ratings
39.22%
Success rate
-3.97%
Average return
Main Sectors:
27 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MCK McKesson | Maintains: Buy | $590 → $670 | $584.83 | +14.56% | 4 | Jun 25, 2024 | |
| HIMS Hims & Hers Health | Maintains: Buy | $22 → $26 | $21.21 | +22.58% | 6 | Jun 13, 2024 | |
| PDCO Patterson Companies | Maintains: Buy | $34 → $32 | $23.92 | +33.78% | 6 | May 20, 2024 | |
| CVS CVS Health | Maintains: Buy | $95 → $77 | $57.52 | +33.87% | 7 | May 2, 2024 | |
| BOLD Boundless Bio | Initiates: Outperform | $25 | $4.30 | +481.40% | 1 | Apr 22, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Market Perform | $23 → $22 | $11.57 | +90.15% | 2 | Mar 18, 2024 | |
| DGX Quest Diagnostics | Initiates: Market Perform | $135 | $136.64 | -1.20% | 1 | Feb 26, 2024 | |
| PGNY Progyny | Initiates: Outperform | $49 | $28.33 | +72.96% | 3 | Feb 26, 2024 | |
| IQV IQVIA Holdings | Initiates: Outperform | $290 | $207.47 | +39.78% | 1 | Feb 26, 2024 | |
| CAH Cardinal Health | Initiates: Outperform | $125 | $96.54 | +29.48% | 4 | Feb 26, 2024 | |
| COR Cencora | Initiates: Outperform | $261 | $222.51 | +17.30% | 1 | Feb 26, 2024 | |
| LH Labcorp Holdings | Initiates: Outperform | $260 | $202.73 | +28.25% | 1 | Feb 26, 2024 | |
| PINC Premier | Initiates: Market Perform | $23 | $18.50 | +21.62% | 3 | Feb 26, 2024 | |
| GDRX GoodRx Holdings | Initiates: Outperform | $8 | $7.82 | +2.30% | 4 | Feb 26, 2024 | |
| DOCS Doximity | Initiates: Market Perform | $32 | $26.96 | +18.69% | 1 | Feb 26, 2024 | |
| CERT Certara | Initiates: Market Perform | $19 | $13.66 | +39.09% | 1 | Feb 26, 2024 | |
| RCM R1 RCM | Initiates: Outperform | $14 | $10.90 | +28.44% | 3 | Feb 26, 2024 | |
| NVST Envista Holdings | Initiates: Underperform | $19 | $16.34 | +16.28% | 4 | Feb 26, 2024 | |
| XRAY DENTSPLY SIRONA | Initiates: Outperform | $42 | $24.44 | +71.85% | 3 | Feb 26, 2024 | |
| ALGN Align Technology | Initiates: Market Perform | $310 | $239.74 | +29.31% | 1 | Feb 26, 2024 | |
| HSIC Henry Schein | Initiates: Market Perform | $78 | $65.60 | +18.90% | 1 | Feb 26, 2024 | |
| ACCD Accolade | Initiates: Outperform | $16 | $3.53 | +353.26% | 6 | Feb 26, 2024 | |
| TDOC Teladoc Health | Initiates: Market Perform | $17 | $9.40 | +80.85% | 1 | Feb 26, 2024 | |
| AKLI Akili | Initiates: Neutral | $2 | $0.43 | +362.96% | 1 | Nov 18, 2022 | |
| GOCO GoHealth | Downgrades: Underperform | $113 → $53 | $10.51 | +399.52% | 2 | Jan 5, 2022 | |
| SONX Sonendo | Initiates: Buy | n/a | $0.08 | - | 1 | Nov 23, 2021 | |
| MDRX Veradigm | Maintains: Buy | n/a | $9.66 | - | 2 | Nov 2, 2018 |
McKesson
Jun 25, 2024
Maintains: Buy
Price Target: $590 → $670
Current: $584.83
Upside: +14.56%
Hims & Hers Health
Jun 13, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $21.21
Upside: +22.58%
Patterson Companies
May 20, 2024
Maintains: Buy
Price Target: $34 → $32
Current: $23.92
Upside: +33.78%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $95 → $77
Current: $57.52
Upside: +33.87%
Boundless Bio
Apr 22, 2024
Initiates: Outperform
Price Target: $25
Current: $4.30
Upside: +481.40%
Walgreens Boots Alliance
Mar 18, 2024
Maintains: Market Perform
Price Target: $23 → $22
Current: $11.57
Upside: +90.15%
Quest Diagnostics
Feb 26, 2024
Initiates: Market Perform
Price Target: $135
Current: $136.64
Upside: -1.20%
Progyny
Feb 26, 2024
Initiates: Outperform
Price Target: $49
Current: $28.33
Upside: +72.96%
IQVIA Holdings
Feb 26, 2024
Initiates: Outperform
Price Target: $290
Current: $207.47
Upside: +39.78%
Cardinal Health
Feb 26, 2024
Initiates: Outperform
Price Target: $125
Current: $96.54
Upside: +29.48%
Cencora
Feb 26, 2024
Initiates: Outperform
Price Target: $261
Current: $222.51
Upside: +17.30%
Labcorp Holdings
Feb 26, 2024
Initiates: Outperform
Price Target: $260
Current: $202.73
Upside: +28.25%
Premier
Feb 26, 2024
Initiates: Market Perform
Price Target: $23
Current: $18.50
Upside: +21.62%
GoodRx Holdings
Feb 26, 2024
Initiates: Outperform
Price Target: $8
Current: $7.82
Upside: +2.30%
Doximity
Feb 26, 2024
Initiates: Market Perform
Price Target: $32
Current: $26.96
Upside: +18.69%
Certara
Feb 26, 2024
Initiates: Market Perform
Price Target: $19
Current: $13.66
Upside: +39.09%
R1 RCM
Feb 26, 2024
Initiates: Outperform
Price Target: $14
Current: $10.90
Upside: +28.44%
Envista Holdings
Feb 26, 2024
Initiates: Underperform
Price Target: $19
Current: $16.34
Upside: +16.28%
DENTSPLY SIRONA
Feb 26, 2024
Initiates: Outperform
Price Target: $42
Current: $24.44
Upside: +71.85%
Align Technology
Feb 26, 2024
Initiates: Market Perform
Price Target: $310
Current: $239.74
Upside: +29.31%
Henry Schein
Feb 26, 2024
Initiates: Market Perform
Price Target: $78
Current: $65.60
Upside: +18.90%
Accolade
Feb 26, 2024
Initiates: Outperform
Price Target: $16
Current: $3.53
Upside: +353.26%
Teladoc Health
Feb 26, 2024
Initiates: Market Perform
Price Target: $17
Current: $9.40
Upside: +80.85%
Akili
Nov 18, 2022
Initiates: Neutral
Price Target: $2
Current: $0.43
Upside: +362.96%
GoHealth
Jan 5, 2022
Downgrades: Underperform
Price Target: $113 → $53
Current: $10.51
Upside: +399.52%
Sonendo
Nov 23, 2021
Initiates: Buy
Price Target: n/a
Current: $0.08
Upside: -
Veradigm
Nov 2, 2018
Maintains: Buy
Price Target: n/a
Current: $9.66
Upside: -